FDA
approval
· 2013-05-06
FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Tribenzor, a fixed-dose combination of olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide, from Cose…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)